About Martin Freed
Form D filings for Avilar Therapeutics in 2023 list Martin Freed as director.
Martin Freed first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Martin Freed in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Martin Freed works with at each company, as listed on that company's latest Form D.
Avilar Therapeutics, Inc. · Form D/A, Feb 13, 2023
TC
Theresa Cameron
Director
Paulina Hill
Director
ST
Stephanie Tozzo
Executive officer
PG
Phil Graham
Executive officer
MD
Milind Deshpande
Director
DN
David Neafus
Executive officer
DG
Daniel Grau
President and director
AM
Adam Muzikant
Executive officer
JR
Joshua Resnick
Director